The largest database of trusted experimental protocols

Alphatrak2

Manufactured by Abbott
Sourced in United States, Israel

The AlphaTrak2 is a blood glucose monitoring system designed for veterinary use. It provides a simple and convenient way to measure blood glucose levels in pets. The device utilizes advanced technology to deliver accurate and reliable results, enabling veterinary professionals to effectively monitor and manage their patients' blood glucose levels.

Automatically generated - may contain errors

23 protocols using alphatrak2

1

Streptozotocin-Induced Diabetic Murine Model

Check if the same lab product or an alternative is used in the 5 most similar protocols
Male C57Bl/6 mice (Taconic Labs) were injected intraperitoneally (i/p) with 55 mg/kg of STZ (Sigma Aldrich, St. Louis, MO) diluted in sterile citrate buffer (0.05 M, pH 4.5) were administered daily for four consecutive days. Control mice received i/p injection of citrate buffer (0.05 M, pH 4.5) alone. At 26 weeks after injection of STZ or citrate buffer all animals were tested for blood glucose level through tail vein puncture and using AlphaTRAK2 (Abbott Diabetes Care Inc., Alameda, CA). Animals with blood glucose levels more than 350 mg/dL were considered diabetic. All experimental protocols were approved by the Animal Care and Use Committee of Xavier University of Louisiana and were conducted in accordance with the ARVO statement for the use of Animals in Ophthalmic and Vision Research.
+ Open protocol
+ Expand
2

Daily Whole Blood Glucose Monitoring

Check if the same lab product or an alternative is used in the 5 most similar protocols
Whole blood glucose levels were measured daily using an AlphaTRAK2 glucose metre (Abbott Diabetes Care Inc., Alameda, CA, USA) from a sterile saphenous vein bleed. Blood glucose values reported here were recorded just prior to skeletal muscle harvest.
+ Open protocol
+ Expand
3

Canine Blood Glucose Screening

Check if the same lab product or an alternative is used in the 5 most similar protocols
Owners of eligible dogs were asked to attend with their dog for a screening appointment, at which signed consent to participate was obtained. Jugular vein blood samples were collected and submitted for biochemistry and haematology, and whole blood glucose measurement was performed using a handheld device (Alphatrak 2; Abbott Diabetes Care Inc., CA, USA) validated for measurement of glucose concentrations in canine blood.
+ Open protocol
+ Expand
4

Assessing Metabolic Physiology in Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
TG clearance was assessed in mice fasted overnight (1700–0900 h) after an oral gavage of 200 μL of food-grade olive oil (Oleoestepa, Estepa, Spain). The rate of hepatic VLDL-TG secretion was assessed after tyloxapol injection (500 mg/kg i.p.; Sigma-Aldrich). Glucose tolerance tests were performed in mice fasted overnight that were injected with 2 mg glucose/g BW i.p. Insulin tolerance tests were performed in mice 4 h after food removal, starting at 0700 h by injecting 1.5 mU insulin/g BW i.p. (Novolin; Novo Nordisk, Bagsvaerd, Denmark). Blood samples were taken from lateral tail vein, and blood glucose measured (AlphaTRAK 2; Abbott Laboratories, Abbott Park, IL). To assess ex vivo WAT lipolysis, 50–60 mg of tissue from urogenital fat pads was washed in cold PBS and minced into small pieces, then incubated in 500 μL Krebs-Ringer HEPES buffer without or with 1 µmol/L isoproterenol for 2 h at 37°C 5% CO2. Media were collected to measure glycerol production (Free Glycerol Reagent; Sigma-Aldrich). Hepatic insulin sensitivity was assessed in mice fasted overnight that were injected with saline or 2 mU/g BW insulin i.p. Twenty minutes later, the liver was collected for Western blot analysis.
+ Open protocol
+ Expand
5

Metformin Effects on Insulin Sensitivity in Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mice generation and protocol as Study 3, except aged 4 to 6 months.
On day of first gavage body weights (mean±SEM) of study groups were
35.1±1.2g; 35.05±1.2g for wild type Vehicle and Metformin
treatment respectively, and 35.08±1.02g; 35.02±1.47g for
Gdf15-/- Vehicle and Metformin treatment
respectively. On day 11, after final dose of metformin mice were fasted for
4 hours. Baseline venous blood sample was collected into heparinised
capillary tube for insulin measurement and blood glucose was measured using
approximately 2 μl blood drops using a glucometer (AlphaTrak2; Abbot
Laboratories) and glucose strips (AlphaTrak2 test 2 strips, Abbot
Laboratories, Zoetis). Mice were given intraperitoneal injection of insulin
(0.5U/kg mouse, Actrapid, NovoNordisk Ltd) and serial mouse glucose levels
measured at time points indicated. Mice were sacrificed by terminal
anaesthesia as in Study 2. Mouse insulin was measured using a 2-plex Mouse
Metabolic immunoassay kit from Meso Scale Discovery Kit (Rockville, MD,
USA), performed according to the manufacturer’s instructions and
using calibrators provided by MSD. Serum metformin levels were quantified
using a stable isotope dilution LC-MS/MS method described
previously33 (link).
+ Open protocol
+ Expand
6

Glyburide Dosage and Blood Glucose Measurement

Check if the same lab product or an alternative is used in the 5 most similar protocols
For glyburide dosing we obtained commercially available generic glyburide tablets of 1.5 mg (Teva) and 1.25 mg (Heritage) each. Blood glucose was measured using a commercially-available glucometer and test strips designed for diabetic monitoring in dogs (AlphaTrak2; Abbott Laboratories, Abbott Park, IL, USA); the performance of this testing method against reference standards has been previously published (Cohen et al., 2009 (link)).
For measurement of glyburide concentration in blood samples, control normal canine plasma was obtained from Equitech-Bio, Inc. (#SCAPE35-0100; Kerrville, TX, USA). Glyburide (USP Reference, #1295505) and Glipizide (G117) reference materials were obtained from Sigma (St. Louis, MO, USA). PBS Buffer, pH 7.0, was made using 8 g NaCl, 0.2 g KCl, 1.44 g Na2HPO4, and 0.24 g KH2PO4 dissolved in 1 L reverse-osmosis deionized (RO-DI) water, pH adjusted to 7.0 with a 6N HCl solution, sourced in-house. All chemicals and reagents were ACS grade and obtained from VWR Scientific (Randor, PA, USA).
+ Open protocol
+ Expand
7

Glucose Tolerance Test in Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Glucose metabolism was assessed on day 0 and day 21 of the experiment.
Mice were fasted for 15–18 hours (overnight), and the next morning
baseline body weight (BW) was recorded. Mice were challenged with
intraperitoneal (ip) glucose (1.5 mg/g BW) consistent with our previous studies
in rodents[18 (link)]. At 0, 15, 30, 60, 90 and
120 min, blood was sampled from the tail for glucose determinations with a
glucometer (AlphaTrak 2, Abbott, IL) At the end of the GTT, mice were returned
to cages and allowed access to food and water. Areas under the curves (AUC) were
calculated by using the trapezoid method [22 ].
+ Open protocol
+ Expand
8

Streptozotocin-Induced Diabetic Model

Check if the same lab product or an alternative is used in the 5 most similar protocols
All animals were made diabetic using a single intraperitoneal injection of streptozotocin (STZ) dissolved in saline (60 mg/kg; Sigma‐Aldrich, St. Louis, MO, USA). A 10% sucrose solution was provided in place of the drinking water for the first 24 hours after STZ administration to prevent hypoglycaemia. After that, the animals received regular drinking water. Diabetes was maintained for a period of 2 weeks, and during this time, blood glucose was monitored twice daily with the AlphaTRAK2 glucometer (Abbott Laboratories; Chicago, IL, USA), and a variable subcutaneous dose of protamine zinc insulin (Boehringer Ingelheim; Duluth, GA, USA) was administered once per day to keep morning glucose levels below 500 mg/dL.
+ Open protocol
+ Expand
9

Recurrent Hypoglycemia Induction Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Recurrent hypoglycaemia was initiated 3 days before the terminal clamp procedure or isoproterenol test. Hypoglycaemia was induced using a single intraperitoneal injection of regular insulin (30–40 IU/kg, Humulin R, Eli Lilly, Indianapolis, IN, USA). Plasma glucose concentrations were monitored through a tail nick every 30 minutes using an AlphaTRAK 2 glucometer (Abbott Laboratories, Chicago, IL, USA), and glucose levels were kept between 30 and 40 mg/dL for at least 1.5 hours (Supplemental Table 1). During recurrent hypoglycaemia, animals had free access to water, but not food. Following each episode of hypoglycaemia, plasma glucose levels were recovered to euglycemic levels by providing free access to food and water. In some cases, 0.5–1 mL of 20% dextrose was injected intraperitoneally to aid recovery if the animals did not eat on their own. Once recovered, the animals were returned to their home cages. This procedure was repeated once daily for 3 consecutive days. Control animals received a saline injection and underwent the same monitoring procedures.
+ Open protocol
+ Expand
10

Canine Glucose, Cytokine, and Adipose Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Blood glucose concentrations were measured with a hand-held point-of-care glucose monitor that was previously validated for use in dogs (AlphaTRAK 2; Abbott Animal Health, Abbott Park, IL, USA). Blood samples for cytokine and hormone analysis were collected into chilled EDTA tubes and plasma was separated within 2 h.
Plasma was stored in −20° C and was analyzed in one batch at the end of the study. The analysis was performed in blind fashion. Plasma levels of canine IL6, MCP1, GMCSF, TNFα, insulin, and leptin were measured with MILLIPLEX MAP Canine Cytokine/Chemokine and Canine Endocrine Magnetic Bead Panels, Millipore/Merck, Darmstadt, Germany, Cat No CCYTOMAG-98K). All samples were tested in duplicates.
Paraffin embedded sections of right and left side of injected falciform fat were used for hematoxylin and eosin staining (H&E), as well as immunohistochemistry analysis using rabbit polyclonal antibodies against mouse UCP1 (Abcam, ab10983, react with canine and mouse UCP1) was performed as previously descriebed15 (link). Antibody was used at 1:1000 dilution.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!